P765: updated enrollment and results from the phase 1 substudy of ivosidenib in patients with idh1-mutant relapsed/refractory myelodysplastic syndrome (r/r mds)
HemaSphere(2022)
关键词
relapsed/refractory myelodysplastic syndrome,myelodysplastic syndrome,ivosidenib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要